These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18437009)

  • 1. Visceral fat thickness predicts fatty liver in Koreans with type 2 diabetes mellitus.
    Kim HJ; Cho MH; Park JS; Nam JS; Kang ES; Ahn CW; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC; Huh KB
    J Korean Med Sci; 2008 Apr; 23(2):256-61. PubMed ID: 18437009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
    Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can increased visceral adiposity without body weight changes accelerate carotid atherosclerosis in South Korean participants with type 2 diabetes?
    Kim CS; Kim SK; Araneta MR; Lee EJ; Barrett-Connor E; Huh KB
    J Diabetes Complications; 2015; 29(8):1085-91. PubMed ID: 26231803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: a population-based study.
    Huang X; Jiang X; Wang L; Chen L; Wu Y; Gao P; Hua F
    J Transl Med; 2019 Oct; 17(1):341. PubMed ID: 31601236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes.
    Bouchi R; Nakano Y; Ohara N; Takeuchi T; Murakami M; Asakawa M; Sasahara Y; Numasawa M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2016 Apr; 15():64. PubMed ID: 27075212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome.
    Pickhardt PJ; Jee Y; O'Connor SD; del Rio AM
    AJR Am J Roentgenol; 2012 May; 198(5):1100-7. PubMed ID: 22528899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
    Eriksson JW; Jansson PA; Carlberg B; Hägg A; Kurland L; Svensson MK; Ahlström H; Ström C; Lönn L; Ojbrandt K; Johansson L; Lind L
    Hypertension; 2008 Dec; 52(6):1030-7. PubMed ID: 18981327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
    Onitsuka Y; Takeshima F; Ichikawa T; Kohno S; Nakao K
    Intern Med; 2014; 53(6):545-53. PubMed ID: 24633023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.
    Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC
    J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond central adiposity: liver fat and visceral fat area are associated with metabolic syndrome in morbidly obese patients.
    Faria G; Gonçalves A; Cunha R; Guimarães JT; Calhau C; Preto J; Taveira-Gomes A
    Int J Surg; 2015 Feb; 14():75-9. PubMed ID: 25599918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.
    Iacobellis G; Pellicelli AM; Grisorio B; Barbarini G; Leonetti F; Sharma AM; Barbaro G
    Obesity (Silver Spring); 2008 Jan; 16(1):179-83. PubMed ID: 18223632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study.
    Misra A; Anoop S; Gulati S; Mani K; Bhatt SP; Pandey RM
    PLoS One; 2015; 10(10):e0140447. PubMed ID: 26474415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between skeletal muscle mass to visceral fat area ratio and arterial stiffness in Chinese patients with type 2 diabetes mellitus.
    Xu J; Pan X; Liang H; Lin Y; Hong Y; Si Q; Shen F; Gu X
    BMC Cardiovasc Disord; 2018 May; 18(1):89. PubMed ID: 29739314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Togashi J; Ohki T; Yoshida H; Omata M; Makuuchi M; Kokudo N
    Transplantation; 2009 Aug; 88(4):575-81. PubMed ID: 19696642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C.
    Iwasa M; Mifuji-Moroka R; Hara N; Ishidome M; Iwata K; Sugimoto R; Tanaka H; Fujita N; Kobayashi Y; Takei Y
    Diabetes Res Clin Pract; 2011 Dec; 94(3):468-70. PubMed ID: 22014765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.